14/12/2017 12:00 (UTC)
Sky team riders upon arrival to the Vanity Glof Hotel, after a training session in Mallorca, Balearic Islands, Sapin, 14 December 2017. The UCI released a statement 13 December 2017 confirming that British rider Christopher Froome was notified of an Adverse Analytical Finding (AAF) of Salbutamol in excess of 1000ng/ml in a sample collected during the Vuelta a Espana on 7 September 2017. EFE/ Cati Cladera
Product Suggestions